Catapult Healthcare: Traveling Nurse Agency Recruitment Is on the Rise (Part 1 of 2)

Choosing an agency as a registered nurse can be a daunting task. According to Nurse.org, “Hospitals are trying to cut costs by reducing the number of travel nurses and renegotiating contracts with staffing agencies, but some agencies are still making big promises to travel nurses that can make the whole situation seem like a bait and switch.”

Gabrielle Bejarano sat down with Paul Shoe, RN contracted through Catapult Healthcare; Suzanne Raymond, National Recruiter at Catapult Healthcare; and Shannon Kanakaole, Recruiting Operations Manager at Catapult Healthcare, to discuss recruiting best practices and how to work effectively with an agency, in Part 1 of a 2-Part podcast series.

“Communication and transparency are at the forefront of the relationship between the agency and the provider,” said Kanakaole. Nurses need to give recruiters clear direction on what they want and expect from a job. Recruiters need to understand the full range of responsibilities and expectations of the roles they are filling to ensure they are finding the best candidate.

“From the initial call, the first and most important thing is understanding the external factors of where they need to be for their next position or assignment,” said Kanakaole. Recruiters need to be clear on the top three priorities of their candidates. Establishing clarity on must-haves and nice-to-haves ensures recruiters can meet candidates’ needs and create a foundation of trust in the relationship. For nurses, that means knowing their desires and communicating them to a recruiter effectively.

As a nurse coming to an agency, Shoe recommended, “make sure all paperwork is up to date” including everything from licenses, medical records, shots, and vaccines. “The more you have ready to go, the quicker we can get you started after an offer,” said Raymond. It streamlines and simplifies the entire process. Once hired, nurses should continue to have open, honest, and frequent conversations with their recruiters. Maintaining the relationship will help when issues or conflicts need to be addressed.

Listen in to learn more about what to look for when seeking agency representation, how to work successfully with an agency, the role of communications, the changing landscape of the traveling nurse industry, and more. And don’t forget to come back for Part II.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More